IntroductionThe global mesenchymal stem cells market is witnessing a significant transformation as advancements in ...

In today’s fast-paced biotechnology landscape, AMSA Biotech emerges as a trailblazer in the field of regenerative medicine. Driven by a vision of science-led healing and personalized care, the company ...

Current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products.

Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies into the clinic.

Bolstered management team with hires of Chief Executive Officer and Chief Medical Officer with deep biopharmaceutical experienceAnnounced selection of IL15-superagonist as first payload to be ...

Beam to Host Investor Webcast on Friday, June 13, 2025, at 4:00 p.m. ET ...

RIT biomedical engineering researchers develop new separation technique for lab-on-chip devices to distinguish cells ...

Gunther Eysenbach, MD, MPH, FACMI, Founding Editor and Publisher; Adjunct Professor, School of Health Information Science, University of Victoria, Canada Linguistic Markers of Pain Communication on X ...